Back
Corbus Pharmaceuticals Holdings Vs. Protalix BioTherapeutics Industry Stock Comparison
Sell
20
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
16.78
Seasonality Move:
14.86%
Buy
64
PLX
Protalix BioTherapeutics
Last Price:
1.18
Seasonality Move:
66.95%
Sell
20
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $16.20. The Score for CRBP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- CRBP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
64
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.17. The Score for PLX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $16.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing slight selling pressure.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.17
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing selling pressure, which indicates risk of future bearish movement.
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.81 | Sell |
| Relative Strength Index (14 RSI): | 24.89 | Sell |
| Chaikin Money Flow: | -58085 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.18 - 20.24) | Sell |
| Bollinger Bands (100): | (27.89 - 59.57) | Sell |
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 64.48 | Buy |
| Chaikin Money Flow: | -127811 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.02 - 1.1) | Buy |
| Bollinger Bands (100): | (0.99 - 1.15) | Buy |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.95 | Sell |
| 20-day SMA: | 18.25 | Sell |
| 50-day SMA: | 35.62 | Sell |
| 200-day SMA: | 38.71 | Sell |
| 8-day EMA: | 16.96 | Sell |
| 20-day EMA: | 20.22 | Sell |
| 50-day EMA: | 30.3 | Sell |
| 200-day EMA: | 34.86 | Sell |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.08 | Buy |
| 20-day SMA: | 1.06 | Buy |
| 50-day SMA: | 1.04 | Buy |
| 200-day SMA: | 1.2 | Sell |
| 8-day EMA: | 1.09 | Buy |
| 20-day EMA: | 1.07 | Buy |
| 50-day EMA: | 1.06 | Buy |
| 200-day EMA: | 1.2 | Sell |
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.97 per share, and a decrease next year of $0.83 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corbus Pharmaceuticals Holdings Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protalix BioTherapeutics Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||